HEALTH MANAGEMENT INTL LTD
SGX: 588
Health Management International - 3QFY18 In Better Shape
- Health Management International (HMI)’s 3QFY18 core net profit (+15.8% y-o-y) was in line; PATMI rose 117% y-o-y.
- Key positives are increasing bill sizes for both inpatient and outpatient, as well as patient volume growth across both hospitals.
- We see competitors’ expansion plans as a possible threat, but improving insurance access and favourable demographics could also benefit the group.
- Synergistic M&As likely a stock catalyst, supported by its strong financial position.
- Maintain ADD with lower Target Price of S$0.80 on higher capex assumptions.
3Q18 core net profit in line, up 15.8% y-o-y
- HMI reported 3QFY18 core net profit of RM15.4m, flat q-o-q but up 15.8% y-o-y and within our/consensus expectations at 26% of full-year forecasts.
- 3Q18 core PATMI rose 117%, thanks to the consolidation of minority interests management undertook in 3Q17.
- We saw both topline growth and margin expansion this quarter, on the back of higher patient load (+2.7% y-o-y), an increase in average bill sizes and effective cost management.
More COEs to boost revenue intensity
- HMI continues to develop its centres of excellence (COEs) and bring in new consultants at both Mahkota and Regency, which led to higher average inpatient bill size (+3.8% y-o-y) and outpatient bill size (+9.0% y-o-y).
- Its attractive positioning for medical tourism and community engagement initiatives remain as key drivers for foreign patient load growth. Bed occupancy ratio was stable at 59% (2Q18: 56%, 3Q17: 63%) despite new ward at Mahkota, as older wards undergo refurbishment and more day surgery beds are added.
Intensifying competition, but structural demand intact
- While land preparation for the new Regency hospital block is underway, there are also more hospitals in the pipeline at both Johor and Malacca.
- We are not overly concerned about rising competition, as structural demand for private healthcare remains intact, protected by local zoning policies and HMI’s early mover advantage.
- Improving insurance penetration (current: 50/50 insured vs. cash-paying patients) and ageing demographics are industry tailwinds for the group, in our view.
Balance sheet strength to support expansionary plans
- Apart from S$11m unutilised proceeds (from share placement to Heliconia) and strong operating cashflow of RM70m-80m per year, HMI also has a low net gearing of 0.1x (0.2x as at end-17), as it continues to pare down the S$53m acquisition debt.
- We think the group is in a strong financial position to pursue both organic and inorganic opportunities, which could be a key re-rating catalyst for the stock.
Maintain ADD
- We tweak our FY18-20F EPS to account for lower revenue assumptions but better margins. Our DCF-based target price drops slightly to S$0.80 (7% WACC) as we adjust for higher capex. Maintain ADD.
- Downside risks include unfavourable regulatory changes, competitive pressure and poor M&A execution.
NGOH Yi Sin
CGS-CIMB
|
https://research.itradecimb.com/
2018-05-10
SGX Stock
Analyst Report
0.80
Down
0.830